JP2017509597A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017509597A5 JP2017509597A5 JP2016549420A JP2016549420A JP2017509597A5 JP 2017509597 A5 JP2017509597 A5 JP 2017509597A5 JP 2016549420 A JP2016549420 A JP 2016549420A JP 2016549420 A JP2016549420 A JP 2016549420A JP 2017509597 A5 JP2017509597 A5 JP 2017509597A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- vaca
- pylori
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14153365.3 | 2014-01-31 | ||
| EP14153365.3A EP2902037A1 (en) | 2014-01-31 | 2014-01-31 | Tolerogenic compositions comprising and uses thereof |
| PCT/IB2015/050703 WO2015114575A1 (en) | 2014-01-31 | 2015-01-30 | Tolerogenic compositions comprising and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017509597A JP2017509597A (ja) | 2017-04-06 |
| JP2017509597A5 true JP2017509597A5 (enExample) | 2018-03-01 |
| JP6563937B2 JP6563937B2 (ja) | 2019-08-21 |
Family
ID=50028895
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016549420A Active JP6563937B2 (ja) | 2014-01-31 | 2015-01-30 | 寛容原性組成物およびその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US9999660B2 (enExample) |
| EP (2) | EP2902037A1 (enExample) |
| JP (1) | JP6563937B2 (enExample) |
| AU (1) | AU2015212357B2 (enExample) |
| CA (1) | CA2943149C (enExample) |
| DK (1) | DK3099314T3 (enExample) |
| ES (1) | ES2806773T3 (enExample) |
| WO (1) | WO2015114575A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11166986B2 (en) | 2014-01-31 | 2021-11-09 | Universitat Zurich | Use of heliocbacter pylori extract for treating or preventing inflammatory bowel diseases and coeliac disease |
| US10973908B1 (en) | 2020-05-14 | 2021-04-13 | David Gordon Bermudes | Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine |
| US12537071B1 (en) | 2020-07-22 | 2026-01-27 | David Gordon Bermudes | Bacteria having boolean control pathways expressing therapeutic proteins including immunotherapeutic cytotoxins |
| AU2024349322A1 (en) * | 2023-09-26 | 2026-04-23 | Atopia Therapeutics Sa | Agents useful for the prevention or treatment of allergic & inflammatory disorders |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002004017A2 (en) * | 2000-07-07 | 2002-01-17 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Method for preparing oral vaccines |
| WO2003018054A1 (en) * | 2001-08-31 | 2003-03-06 | Chiron Srl. | Helicobacter pylori vaccination |
| JP2004189730A (ja) * | 2002-11-28 | 2004-07-08 | Japan Science & Technology Agency | 細胞死の抑制方法、細胞死抑制剤、及びその細胞死抑制剤を含む細胞死に起因する疾患の治療薬剤 |
| US11166986B2 (en) | 2014-01-31 | 2021-11-09 | Universitat Zurich | Use of heliocbacter pylori extract for treating or preventing inflammatory bowel diseases and coeliac disease |
-
2014
- 2014-01-31 EP EP14153365.3A patent/EP2902037A1/en not_active Withdrawn
-
2015
- 2015-01-30 EP EP15708316.3A patent/EP3099314B1/en active Active
- 2015-01-30 ES ES15708316T patent/ES2806773T3/es active Active
- 2015-01-30 CA CA2943149A patent/CA2943149C/en active Active
- 2015-01-30 JP JP2016549420A patent/JP6563937B2/ja active Active
- 2015-01-30 US US15/115,377 patent/US9999660B2/en active Active
- 2015-01-30 DK DK15708316.3T patent/DK3099314T3/da active
- 2015-01-30 AU AU2015212357A patent/AU2015212357B2/en active Active
- 2015-01-30 WO PCT/IB2015/050703 patent/WO2015114575A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016509011A5 (enExample) | ||
| JP2016539946A5 (enExample) | ||
| RU2016146801A (ru) | Вакцинная композиция против инфекции, вызванной streptococcus suis | |
| JP2014502156A5 (enExample) | ||
| NZ701881A (en) | Vaccines for hsv-2 | |
| JP2014530010A5 (enExample) | ||
| JP2015164424A5 (enExample) | ||
| JP2015521467A5 (enExample) | ||
| JP2019533722A5 (enExample) | ||
| JP2017532343A5 (enExample) | ||
| JP2014508734A5 (enExample) | ||
| RU2016152151A (ru) | Препарат, содержащий фактор viii и пептиды фактора фон виллебранда | |
| JP2018520651A (ja) | 短縮型ロタウイルスｖｐ４タンパク質およびその適用 | |
| CN103687942A (zh) | 病毒样颗粒及其制备方法 | |
| CN103467571A (zh) | 一种畜禽免疫增强剂法氏囊多肽 | |
| JP2014519817A5 (enExample) | ||
| JP2016520534A5 (enExample) | ||
| JP2014139185A5 (enExample) | ||
| HRP20241627T1 (hr) | Pneumolizinski mutanti i postupci za njihovu uporabu | |
| Schülke et al. | Fusion protein of TLR5-ligand and allergen potentiates activation and IL-10 secretion in murine myeloid DC | |
| CN109200284B (zh) | 一种猪支原体肺炎活疫苗黏膜免疫佐剂、制备方法及其应用 | |
| JP2014502143A5 (enExample) | ||
| RU2018112060A (ru) | Слитый белок | |
| ES2367128T3 (es) | Procedimiento para preparar una variante del antígeno protector de superficie de erysipelothrix rhusiopathiae en e. coli. | |
| JP2019534242A5 (enExample) |